Skip to main content
Veterinary Medicines

Viruvetsan-N

Authorised
  • ECHINACEA D1
  • BUFO RANA D10
  • Coffea arabica mother tincture

Product identification

Medicine name:
Viruvetsan-N
Active substance:
  • ECHINACEA D1
  • BUFO RANA D10
  • Coffea arabica mother tincture
Target species:
  • Sheep
  • Pig
  • Cat
  • Goat
  • Cattle
  • Horse
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • ECHINACEA D1
    50.00
    milligram(s)
    /
    5.00
    millilitre(s)
  • BUFO RANA D10
    50.00
    milligram(s)
    /
    5.00
    millilitre(s)
  • Coffea arabica mother tincture
    50.00
    milligram(s)
    /
    5.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Cat
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Dog
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Deutsche Homoeopathie-Union DHU-Arzneimittel GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Deutsche Homoeopathie-Union DHU-Arzneimittel GmbH & Co. KG
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 6402879.00.00
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."